Other
Opioid Analgesia
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Opioid Analgesia is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
14
clinical trials
Completed9 · 64%
Active, not recruiting2 · 14%
Withdrawn1 · 7%
Unknown status1 · 7%
Recruiting1 · 7%
Clinical Trials
Trial Activity
14 trials
Non-opioid Analgesia for Fast-track Surgery
Completed·MMcGill University Health Centre/Research Institute of the McGill University Health Centre·N/A·NCT01275911·40 enrolled
μ-opioid Receptor Polymorphism and Opioid Analgesia
Completed·—·N/A·NCT02099877·250 enrolled
Assessment of Opioid Analgesia in Sickle Cell
Withdrawn·—·Phase 4·NCT00513864
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)